Dr Aaron Yuntai Lee, MD in Seattle, WA - Medicare Ophthalmology

Dr Aaron Yuntai Lee, MD is a medicare enrolled "Ophthalmology" physician in Seattle, Washington. His current practice location is 1660 S Columbian Way, Seattle, Washington. You can reach out to his office (for appointments etc.) via phone at (206) 543-7250.

Dr Aaron Yuntai Lee is licensed to practice in Washington (license number MD60410204) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1063649713.

Contact Information

	Dr Aaron Yuntai Lee, MD
	1660 S Columbian Way, Seattle, WA 98108-1532
	(206) 543-7250
	Not Available

Physician's Profile

Full Name	Dr Aaron Yuntai Lee
Gender	Male
Speciality	Ophthalmology
Location	1660 S Columbian Way, Seattle, Washington
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1063649713
Provider Enumeration Date: 06/19/2009
Last Update Date: 08/18/2015

Medicare PECOS Information:

PECOS PAC ID: 7719290493
Enrollment ID: I20150723009632

Medical Identifiers

Medical identifiers for Dr Aaron Yuntai Lee such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1063649713	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	MD60410204 (Washington)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Aaron Yuntai Lee allows following entities to bill medicare on his behalf.

Entity Name	The Association Of University Physicians
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244

News Archive

AstraZeneca's vandetanib receives FDA approval in medullary thyroid cancer

AstraZeneca today announced that the U.S. Food and Drug Administration approved the orphan drug vandetanib for the treatment of medullary thyroid cancer that cannot be removed by surgery or that has spread to other parts of the body.

Global Health Initiative launched by The Association of University Technology Managers

The Association of University Technology Managers (AUTM) announced the launch of a new Global Health Initiative that promotes licensing practices that support access to essential medicines by developing countries.

Largest clinical trial to compare surgical treatments for congenital heart disease

Pediatric researchers report that a recently introduced surgical procedure offers infants with severely underdeveloped hearts a better chance at surviving during their first year of life, in comparison to the standard surgery.

Non-Hispanic black women more likely to die from breast cancer

Non-Hispanic black women diagnosed with breast cancer, specifically those with estrogen receptor-positive tumors, are at a significantly increased risk for breast cancer death compared with non-Hispanic white women.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Aaron Yuntai Lee is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Aaron Yuntai Lee, MD 1660 S Columbian Way, Seattle, WA 98108-1532 Ph: (206) 543-7250	Dr Aaron Yuntai Lee, MD 1660 S Columbian Way, Seattle, WA 98108-1532 Ph: (206) 543-7250

News Archive

AstraZeneca's vandetanib receives FDA approval in medullary thyroid cancer

Global Health Initiative launched by The Association of University Technology Managers

Largest clinical trial to compare surgical treatments for congenital heart disease

Non-Hispanic black women more likely to die from breast cancer

Ophthalmology Doctors in Seattle, WA

Rika Shirakawa, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1959 Ne Pacific St, Box 365485, Seattle, WA 98195 Phone: 206-558-9616
Dr. Ted M Zollman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1101 Madison St, Ste. 600, Seattle, WA 98104 Phone: 206-215-2020 Fax: 206-215-2022
Timothy Patrick Carey, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5116 25th Ave Ne, Seattle, WA 98105 Phone: 206-522-2500 Fax: 206-269-8307
Kristina Tarczy-hornoch, M.D Ophthalmology Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, M/s W-7729, Seattle, WA 98105 Phone: 206-987-3670
Miss Miel Sundararajan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000
Arthika Chandramohan, Ophthalmology Medicare: Medicare Enrolled Practice Location: 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-520-5000
Eun Sara Huh, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10330 Meridian Ave N, Suite 370, Seattle, WA 98133 Phone: 206-528-6000 Fax: 206-528-0014

Dr Aaron Yuntai Lee, MD - Medicare Ophthalmology in Seattle, WA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

AstraZeneca's vandetanib receives FDA approval in medullary thyroid cancer

Global Health Initiative launched by The Association of University Technology Managers

Largest clinical trial to compare surgical treatments for congenital heart disease

Non-Hispanic black women more likely to die from breast cancer

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

AstraZeneca's vandetanib receives FDA approval in medullary thyroid cancer

Global Health Initiative launched by The Association of University Technology Managers

Largest clinical trial to compare surgical treatments for congenital heart disease

Non-Hispanic black women more likely to die from breast cancer

Ophthalmology Doctors in Seattle, WA